Frequencies for first 10,000 rows of lit_ref variable in demo2018q4 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,248 92.48 92.48 , ANDERSSON H, LUND M, SEM M, GRAN J,.. | 1 0.01 92.49 , BURNHAM E, CLARK B, HO P, ALLEN R, .. | 1 0.01 92.50 , CETIN C, METBAN M, ERDUGAN M, OGUZ .. | 1 0.01 92.51 , CLARK P, SINGH A, GE D AND FELLAY J.. | 1 0.01 92.52 , DISTLER O, KUWANA M, ALLANORE Y AND.. | 1 0.01 92.53 , FISHKIN P. LAPLAN B. DRAKE M. KURT.. | 1 0.01 92.54 , FOX C, BODEN A, BLOOR A, DUNGAWALLA.. | 1 0.01 92.55 , FRIEDBERG J, PARK S, MCDONAGH K, HA.. | 1 0.01 92.56 , HATAKEYAMA S, YAMAMOTO H, FUJITA T,.. | 1 0.01 92.57 , JANSS A, MAZEWSKI C, CASTELLINO R, .. | 1 0.01 92.58 , KACER M, HRUBA P, HERMANOVA H, HES .. | 1 0.01 92.59 , KANJO N, KIMIZUA K, OGURA M, SUGIYA.. | 1 0.01 92.60 , KASHIWABA M, SAITO T, ET AL A CASE .. | 1 0.01 92.61 , LUND M, SEM M, GRAN J, AND MOLBERG .. | 1 0.01 92.62 , MACHIDA H, IIDA T, IKEDA M, SHIDA M.. | 1 0.01 92.63 , MARTIN P, CHRISTOS P, CERCHIETTI L,.. | 1 0.01 92.64 , MARTIN P, CHRISTOS P, CERCHIETTI L,.. | 1 0.01 92.65 , MARTIN P, CHRISTOS P, CERCHIETTI L,.. | 3 0.03 92.68 , MARTIN P, CHRISTOS P, CERCHIETTI L,.. | 1 0.01 92.69 , MARTIN P, CHRISTOS P, CERCHIETTI L,.. | 2 0.02 92.71 , MOLBERG O, LUND M, AND GRAN J. RITU.. | 1 0.01 92.72 , NOVELLO S, RAMLAU R, FAVARETTO A, B.. | 1 0.01 92.73 , RAJWA P, PARADYSZ A AND BRYNIARSKI .. | 1 0.01 92.74 , SCOTT L, REEVES B, DOWNES S, LOTERY.. | 1 0.01 92.75 , SEM M, LUND M , AALOKKE T, GUNTHER.. | 1 0.01 92.76 , SEM M, LUND M , AALOKKEN T, GUNTHE.. | 1 0.01 92.77 , SEM M, LUND M , AALOKKEN T, GUNTHE.. | 1 0.01 92.78 , SEM M, LUND M , AALOKKEN T, GUNTHER.. | 1 0.01 92.79 , STENEHJEM D, WADE M, WEIS J, MCGREG.. | 1 0.01 92.80 , STEVENSON J, LANGER C, GANDHI L, BO.. | 1 0.01 92.81 , SUGITA Y, MOMOSAKI S, ITO Y, WAKUGA.. | 1 0.01 92.82 , TAGURI M, YAMAZAKI K, TSURUTANI J, .. | 1 0.01 92.83 , TANNA A, MCADOO S, MEDJERAL-THOMAS .. | 1 0.01 92.84 , TOBINAI K, WAKABAYASHI M, MORISHIMA.. | 1 0.01 92.85 , UEHARA K, HIRAMATSU K, MAEDA A, SAK.. | 1 0.01 92.86 , VAN DER VLIES E, TEN BOKKEL HUININK.. | 1 0.01 92.87 , VIRDEE P, EATOCK M, LORD S, FALK S,.. | 1 0.01 92.88 , WADA Y, KUROSAWA Y, YAMAMOTO S, TAN.. | 1 0.01 92.89 , WHELESS J, ROGIN J, WOLTER K, PIXTO.. | 1 0.01 92.90 , WILDIERS H, FREYER G, KEMENY M, GON.. | 1 0.01 92.91 , WU D, MARTIN D, PHILIP M, SHUSTOV A.. | 1 0.01 92.92 , ZHAO Q, ZHANG H, HAN C, JIN Z, NAN .. | 1 0.01 92.93 A S. ERWORBENE HEMMKRPERHAEMOPHILIE B.. | 1 0.01 92.94 AAGAARD L, HANSEN E. PRESCRIBING OF M.. | 1 0.01 92.95 ABD-ELSAYED A, ELSHARKAWY H, SAKR W. .. | 1 0.01 92.96 ABD-ELSAYED, A.. A SEVERE INTERACTION.. | 1 0.01 92.97 ABE S, OKADA Y, SATO T, SUZUKI K. MUL.. | 1 0.01 92.98 ABE S, OKADA Y, SATO T, SUZUKI K. MUL.. | 1 0.01 92.99 ABRAMOWICZ M. IN BRIEF: SEVERE BRADYC.. | 1 0.01 93.00 ABUGHANIMEH O, GHANIMEH M, QASRAWI A... | 1 0.01 93.01 ABUGHANIMEH O, GHANIMEH MA, QASRAWI A.. | 1 0.01 93.02 ABUGHANIMEH O, GHANIMEH MA, QASRAWI A.. | 1 0.01 93.03 ABUGHANIMEH, O.. POSTERIOR REVERSIBLE.. | 1 0.01 93.04 ADACHI S, NARUI K, YAMADA A, SUGAE S,.. | 1 0.01 93.05 ADARSH VOHRA. QUETIAPINE INDUCED REST.. | 1 0.01 93.06 ADARSH VOHRA. QUETIAPINE INDUCED REST.. | 1 0.01 93.07 ADVANI ET. AL. P. 5-FU-INDUCED HYPERA.. | 1 0.01 93.08 AFSHAN S,FARAH MUSA A,ECHOLS V,LERANT.. | 1 0.01 93.09 AL-JASHAAMI, L.. SEVERE CHOLESTATIC L.. | 1 0.01 93.10 AL-MARRAWI, M.. CONSOLIDATION WITH RA.. | 1 0.01 93.11 ALAO A, LEWKOWICZ C. SEEING DOUBLE: S.. | 1 0.01 93.12 AMARAKOON S, MARTINEZ-CIRIANO J, VAN .. | 1 0.01 93.13 AMBAPKAR SN, SHETTY N, DWIVEDY A. STA.. | 1 0.01 93.14 ANG G, ZAYED H, SLAVOTINEK A AND RUTL.. | 1 0.01 93.15 ANTHONY RM, PRIOTY I, CATHERINE D, L.. | 1 0.01 93.16 ANTHONY RM, PRIOTY I, CATHERINE D, LA.. | 1 0.01 93.17 ARAI K. A CASE WHERE A BOY WITH INTRA.. | 1 0.01 93.18 ARAUJO A, MARCAL M, TUNA M, ANJOS R. .. | 1 0.01 93.19 ARAUJO JJ. RESTRICTIVE DUCTUS ARTERIO.. | 1 0.01 93.20 ARAUJO, A.. CARDIAC DYSFUNCTION AND P.. | 1 0.01 93.21 ARELLANO AL, MARTIN-SUBERO M, MONERRI.. | 1 0.01 93.22 ARITA Y, TAGUCHI H, KOBAYASHI M, TONO.. | 1 0.01 93.23 ARNAUTOVIC J, TEREZIU S. SLOWING THE .. | 1 0.01 93.24 ARNOLD, P.. SEVERE HYPERSENSITIVITY R.. | 2 0.02 93.26 ASANUMA S, NOGUCHI S, YASUMOTO A, WAD.. | 1 0.01 93.27 ASEMOTA, E.. GEMCITABINE-INDUCED PSEU.. | 1 0.01 93.28 ATEFI D, PINTO SANDER N, RICHARDSON D.. | 1 0.01 93.29 ATEFI D, PINTO-SANDER N, RICHARDSON D.. | 1 0.01 93.30 AUERBACH ET.AL J. CIPROFLOXACIN-INDUC.. | 1 0.01 93.31 B J. | 1 0.01 93.32 BABA Y, TANESE K, AMAGAI M, KAMEYAMA .. | 1 0.01 93.33 BACHOUMAS K, FIANCETTE M, LASCARROU J.. | 1 0.01 93.34 BAGOT M, RAM-WOLFF C, MALPHETTES M, B.. | 1 0.01 93.35 BAGOT, C R, M M, P B. OCCURRENCE OF T.. | 1 0.01 93.36 BALKI M ET AL. STATUS EPILEPTICUS AFT.. | 1 0.01 93.37 BELVER MT, MICHAVILA A, BOBOLEA I, FE.. | 1 0.01 93.38 BELVER MT, MICHAVILA A, BOBOLEA I, FE.. | 1 0.01 93.39 BELVER, M.. SEVERE DELAYED SKIN REACT.. | 1 0.01 93.40 BERGER C, FIORELLI M, STEINER T, SCHA.. | 1 0.01 93.41 BHATTY M, KATO S, PIHA-PAUL S, NAING .. | 1 0.01 93.42 BLAIR, P.. DRESS SYNDROME PRESENTING .. | 1 0.01 93.43 BOBOLEA I, BARRANCO P, FIANDOR A, CAB.. | 1 0.01 93.44 BOGOMOLOV P, MACIEVICH M, BUEVEROV A... | 1 0.01 93.45 BOHM KJ, CIRALSKY JB, HARP JL, BAJAJ .. | 1 0.01 93.46 BOHM, K.. CICATRIZING CONJUNCTIVITIS .. | 1 0.01 93.47 BONNECAZE AK, STEPHENS SE, MILLER PJ... | 1 0.01 93.48 BONNET, U.. ON THE RISK OF DEPENDENCE.. | 1 0.01 93.49 BOOTH K. A., HAYS C. I.. USING DENOSU.. | 1 0.01 93.50 BORGIA G, REYNAUD L, GENTILE I, BORRE.. | 1 0.01 93.51 BOSE S, WURM E, POPOVICH M, SILVER B... | 1 0.01 93.52 BOSSAER, J.. DRUG INTERACTION BETWEEN.. | 1 0.01 93.53 BOUCHER J, BRENNER SM. FATAL CARDIAC .. | 1 0.01 93.54 BOUMA G, IMHOLZ A ILEITIS FOLLOWING C.. | 1 0.01 93.55 BRADEE AR, LEHMAN A, REED RC, WATSON .. | 1 0.01 93.56 BRANDT C, FUERATSCH N, BOEHME V, KRAM.. | 1 0.01 93.57 BRASILEIRO A, CAMPOS S, FIDALGO A. DO.. | 1 0.01 93.58 BRENNER, S.. FATAL CARDIAC ARREST IN .. | 1 0.01 93.59 BROMS G, GRANATH F, EKBOM A, HELLGRE.. | 1 0.01 93.60 BRUCHFELD A, BARANY P, HEDSTROM A AND.. | 1 0.01 93.61 BYVAL^TSEV VA, BUDAEV AE, SOROKOVIKOV.. | 1 0.01 93.62 C THURTELL, APB TASKER, G BRENNAN AND.. | 1 0.01 93.63 CA S. | 1 0.01 93.64 CAGANOVA B. CAN THE USE OF OTC DRUGS .. | 1 0.01 93.65 CAGANOVA, B.. IBUPROFEN, DOBRY SLUHA .. | 2 0.02 93.67 CARMO J, MARQUES SC, BISPO M, PINTO D.. | 1 0.01 93.68 CARVAJAL A. TEMOZOLOMIDE AND OESOPHAG.. | 1 0.01 93.69 CARVAJAL A. TEMOZOLOMIDE AND OESOPHAG.. | 1 0.01 93.70 CASTRO D, GONCALVES J, BRAGA J. ACUTE.. | 1 0.01 93.71 CHAM, S.. MOOD, PERSONALITY, AND BEHA.. | 1 0.01 93.72 CHENG J, KOWALIS M, EVANS J, EVANS B,.. | 1 0.01 93.73 CHEUNG J, WU M, GABRIELS J, KHAN M, S.. | 1 0.01 93.74 CHIARA PECORI. PATERNAL THERAPY WITH .. | 2 0.02 93.76 CHUDOW M, FERGUSON K. A CASE OF SEVER.. | 1 0.01 93.77 CIBICEK, N.. MULTI-DRUG INTOXICATION .. | 1 0.01 93.78 COBB MI, ZOMORODI AR, HAUCK EF, SMITH.. | 1 0.01 93.79 COLACO, BRENDON, MANSUKHANI, MEGHNA. .. | 1 0.01 93.80 COLE J. HIGH DOSE INSULIN FOR BETA-BL.. | 1 0.01 93.81 COLE J. HIGH DOSE INSULIN FOR BETA-BL.. | 1 0.01 93.82 COLE J. HIGH DOSE INSULIN FOR BETA-BL.. | 1 0.01 93.83 COLE JB, ARENS AM, LAES JR, KLEIN LR,.. | 4 0.04 93.87 COLE JB, STELLPFLUG SJ, ENGEBRETSEN K.. | 1 0.01 93.88 COLE JB, STELLPFLUG SJ, SMITH SW. REF.. | 1 0.01 93.89 COLLINS RD, TVERDEK FP, BRUNO JJ, COY.. | 1 0.01 93.90 COLLINS, R.. PROBABLE NONCONVULSIVE S.. | 1 0.01 93.91 COLUCCI.. SUICIDE BY SELF ADMINISTRAT.. | 1 0.01 93.92 COSKUN A, YAVASOGLU I, HADI YASA M, .. | 1 0.01 93.93 COSKUN A, YAVASOGLU I, HADI YASA M, .. | 1 0.01 93.94 COSKUN A, YAVASOGLU I, HADI YASA M, C.. | 1 0.01 93.95 COSKUN A, YAVASOGLU I, HADI YASA M, C.. | 1 0.01 93.96 COSTA C, AGUIAR R, RODRIGUES M, CARVA.. | 1 0.01 93.97 COSTALLAT, B.. MYELOPATHY IN SYSTEMIC.. | 3 0.03 94.00 COYNE JD, CAMPBELL F.. MICROSCOPIC FE.. | 1 0.01 94.01 CRIVELLARI D, SPAZZAPANS, LOMBARDI D,.. | 1 0.01 94.02 CUMPSTON KL, GOPAUL R, WILLS B.. ADJU.. | 1 0.01 94.03 CUMPSTON, K.. ADJUNCTIVE USE OF LOW-D.. | 1 0.01 94.04 CURTIS S, HONG S, GUCALP R, CALVO M. .. | 1 0.01 94.05 DABBERT D, ZIMMERMANN J, TOTO S, GROH.. | 1 0.01 94.06 DABBERT, D.. EGO-DYSTONIC SUICIDAL TH.. | 1 0.01 94.07 DAMIANI GR, LANDI S, PELLEGRINO A, LO.. | 2 0.02 94.09 DANAN J, HEITZ A, BOURCIER T. PERIORB.. | 1 0.01 94.10 DARLING, S.. FENTANYL TEA. UGESKRIFT .. | 1 0.01 94.11 DAVER N. EFFICACY, SAFETY AND BIOMARK.. | 1 0.01 94.12 DE MAGALHAES F, KUMAR MT. PERSISTENT .. | 1 0.01 94.13 DE MAGALHAES FJC, ET AL.. CITALOPRAM .. | 1 0.01 94.14 DE OLIVEIRA W, BORSATO M, DABRONZO M,.. | 1 0.01 94.15 DEDEMADI G, KOUKOULAKI M, VOUGAS V, N.. | 1 0.01 94.16 DELEUZE, C.. DOCETAXEL : 48 DEATHS IN.. | 1 0.01 94.17 DEMERS MF, FORTIER L, BREAULT AS, LEH.. | 1 0.01 94.18 DESAI A, KHERALLAH Y, SZABO C, MARAWA.. | 1 0.01 94.19 DIAS, A.. LYTIC BONE LESION BY BRUCEL.. | 1 0.01 94.20 DIDIER K, BEGUINOT I, ABOU-TAAM M, SE.. | 1 0.01 94.21 DIE DINGE SIND NICHT IMMER DAS, WAS S.. | 1 0.01 94.22 DIPESH HV, JIMMY KL, SIMON PB, ALEC B.. | 1 0.01 94.23 DLUGOSZ-DANEKA M, JURCZAK W, OLSZANEC.. | 1 0.01 94.24 DO JL, ARCAND L, NARANG P, LIPPMANN S.. | 1 0.01 94.25 DOI.ORG/10.1007/S00198-018-4793-1 CHE.. | 2 0.02 94.27 DOI.ORG/10.1016/J.CLGC.2018.08.006 BO.. | 5 0.05 94.32 DOI: 10.1080/24725625.2017.1417673#. .. | 1 0.01 94.33 DOI: 10.5301/TJ.5000312#. TABERNER BO.. | 1 0.01 94.34 DOSHITA K, NAKAMURA K, SUZUKI H, KURO.. | 1 0.01 94.35 DUMESTRE-TOULET, V.. LAST PERFORMANCE.. | 1 0.01 94.36 DYSON J, HUTCHINSON J, HARRISON L, RO.. | 2 0.02 94.38 DYSON J, HUTCHINSON J, HARRISON L, RO.. | 1 0.01 94.39 DYSON J, HUTCHINSON J, TINIAKOS D, FO.. | 1 0.01 94.40 DYSON JK, HUTCHINSON J, HARRISON L, R.. | 1 0.01 94.41 EARL D. SILVERMAN. NEOPLASMS IN PEDIA.. | 1 0.01 94.42 EBENS C.L., SMITH A.R., VERGHESE P.S... | 1 0.01 94.43 EFFERTH T, SCHOTTLER U, KRISHNA S, ET.. | 1 0.01 94.44 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 94.45 ELISAF, M. DISORDERS OF POTASSIUM HOM.. | 1 0.01 94.46 ENOKIYA, T.. DELAYED ELIMINATION HALF.. | 1 0.01 94.47 ENSAT F, EDELBAUER M, WECHSELBERGER G.. | 1 0.01 94.48 EPSTEIN J, GHARAPETIAN S, REJALI A, Z.. | 1 0.01 94.49 ERIN DOHANEY, MARK SEAMONE AND RUDRA .. | 1 0.01 94.50 ESTEVE M, SARO C, GONZALEZ-HUIX F, SU.. | 1 0.01 94.51 EVENS AM, ADVANI R, PRESS OW, LOSSOS .. | 1 0.01 94.52 FABER, E.. RHABDOMYOLYSIS AFTER COADM.. | 1 0.01 94.53 FAINSINGER, R.. PALLIATIVE CARE ROUND.. | 1 0.01 94.54 FAMULARO G, MINISOLA G, BRAVI M, COLU.. | 1 0.01 94.55 FARAJI, F.. BLINDNESS RESULTING FROM .. | 1 0.01 94.56 FARRELL, B.. MANAGING CHRONIC DISEASE.. | 1 0.01 94.57 FERASTRAOARU D, KORANSKY R, JERSCHOW .. | 1 0.01 94.58 FILIPESCU I, PAMFIL C, DUMITRU B, GAR.. | 1 0.01 94.59 FIRST CASES OF ZOLEDRONIC ACID-INDUCE.. | 1 0.01 94.60 FLEISCHMANN, R.. IMPACT OF GLUCOCORTI.. | 1 0.01 94.61 FLORENT GUERVILLE. SYNDROME OF INAPPR.. | 1 0.01 94.62 FONSECA R, MARIZ E, BERNARDES M, COST.. | 2 0.02 94.64 FONTANA RJ, HUGHES EA, APPELMAN H, HI.. | 1 0.01 94.65 FOTIADOU C, LAZARIDOU E, SOTIRIOU E, .. | 1 0.01 94.66 FRAGOSO Y. GLATIRAMER ACETATE TO TREA.. | 1 0.01 94.67 FRYDRYCHOWICZ C, PASIEKA B, PIERER M,.. | 1 0.01 94.68 GADUPUTI V, TARIQ H, IHIMOYAN A. A RA.. | 1 0.01 94.69 GAHA, M.. DRESS SYNDROME: CEREBRAL VA.. | 1 0.01 94.70 GAJJAR K, HIRAPARA H, JAISWAL CS, BAR.. | 1 0.01 94.71 GALINKO, L.. A BASIC THERAPY GONE AWR.. | 1 0.01 94.72 GARCIA DE VEAS SILVA J, BERMUDO GUITA.. | 1 0.01 94.73 GARCIA J. PROGRESSIVE MULTIFOCAL LEUK.. | 1 0.01 94.74 GASS-JEGU F, GSCHWEND A, GAIRARD-DORY.. | 1 0.01 94.75 GAYAM V,SHRESTHA B,KHALID M,RAJIB HOS.. | 1 0.01 94.76 GEIJTEMAN ECT, WENSVEEN CWM, DUVEKOT .. | 1 0.01 94.77 GEORG, PILZ. PANITUMUMAB-ASSOCIATED E.. | 1 0.01 94.78 GEORGE AK, KUNWAR AR, AWASTHI A.. ACU.. | 1 0.01 94.79 GHIRINGHELLI F. FLUOROURACIL, LEUCOVO.. | 1 0.01 94.80 GHIRINGHELLI, F.. FLUOROURACIL, LEUCO.. | 1 0.01 94.81 GNARRA M, SOLMAN L, HARPER J, BATUL S.. | 1 0.01 94.82 GOPALRATNAM, K.. A CASE OF MYXOFIBROS.. | 1 0.01 94.83 GOPALRATNAMA K, RODRIGUEZ JA, WOODSON.. | 1 0.01 94.84 GREBENCIUCOVA E, BERGER J. PROGRESSIV.. | 3 0.03 94.87 GREBENCIUCOVA E, BERGER J. PROGRESSIV.. | 1 0.01 94.88 GREGOIRE M, BRETONNIERE C, DESLANDES .. | 1 0.01 94.89 GRONEWOLD, A.. DOXEPIN AND NORDOXEPIN.. | 2 0.02 94.91 GUERN AL, ALKERAYE S, VERMERSCH-LANGL.. | 1 0.01 94.92 GUPTA A, MODY P, PANDEY A. INAPPROPRI.. | 1 0.01 94.93 HAAS J, SINGER T, NOWAK K, BRUST J, G.. | 1 0.01 94.94 HAKKINEN, M.. PROFILES OF PREGABALIN .. | 1 0.01 94.95 HALL A, SMOLINSKE SC, CONRAD FL, WRUK.. | 1 0.01 94.96 HAMADA R, HORI T, YAMAMOTO M, IGARASH.. | 1 0.01 94.97 HAMEL J, CIAFALONI E. TEMPORAL AND SP.. | 1 0.01 94.98 HAMEL J, CIAFALONI E. TEMPORAL AND SP.. | 1 0.01 94.99 HANAZAWA T. THREE CASES OF PATIENTS W.. | 1 0.01 95.00 HARBECK C. MISLEADING CASE REPORT ON .. | 1 0.01 95.01 HAROON N, RAZA S, BHAT Z. HYPOMAGNESE.. | 1 0.01 95.02 HAROON, N.. HYPOMAGNESEMIA AND CHEMOT.. | 1 0.01 95.03 HASE, J.. TRIMETHOPRIM-SULFAMETHOXAZO.. | 1 0.01 95.04 HASLBAUER U. THERAPY SEQUENCE WITH EG.. | 1 0.01 95.05 HAUER T. REAL-LIFE EXPERIENCE WITH TH.. | 1 0.01 95.06 HENSLEY, M.. A LARGE CASE SERIES OF A.. | 1 0.01 95.07 HERNANDEZ LAIN A, HILARIO A, SEPULVED.. | 1 0.01 95.08 HILL F, MCCLOSKEY S, SHEERIN N. FROM .. | 1 0.01 95.09 HIRANO T. CLINICAL INVESTIGATION EFFE.. | 1 0.01 95.10 HIRATA K. JOURNAL OF JAPAN SOCIETY OF.. | 1 0.01 95.11 HIRAYAMA, YOJI. ACUTE ADRENAL INSUFFI.. | 1 0.01 95.12 HIROHATA M, ISHII Y, OYAMA K, MATSUNO.. | 1 0.01 95.13 HIRSCH P, MAMEZ AC, BELHOCINE R, LAPU.. | 1 0.01 95.14 HIRUNAGI T. A CASE OF ANTI-MI-2 ANTIB.. | 1 0.01 95.15 HISAHARA H, ET AL. DEVELOPMENT OF SIA.. | 1 0.01 95.16 HIYAMA Y, KATAOKA T AND SHIBATA Y AN .. | 1 0.01 95.17 HO J. TAXANE-INDUCED MYOSITIS: A CASE.. | 1 0.01 95.18 HO, J.. TAXANE-INDUCED MYOSITIS: A CA.. | 1 0.01 95.19 HOELTZENBEIN, M., ET AL... INCREASED .. | 1 0.01 95.20 HOFFMANN, M.. ACUTE BENZODIAZEPINE TO.. | 1 0.01 95.21 HOFMANN M, OVERMAN M, NATES J. ACUTE .. | 1 0.01 95.22 HOGAN, M.. FDG-AVID INTRATHECAL INFLA.. | 1 0.01 95.23 HONDA Y. LETTERS TO THE EDITOR EXTERN.. | 1 0.01 95.24 HORIKAWA YT, UDAKA TY, CROW JK, TAKAY.. | 1 0.01 95.25 HORVATH R, SZENCZI O, RIGO J, BALINT .. | 1 0.01 95.26 HOSKOTE SS, ANNAPUREDDY N, RAMESH AK,.. | 1 0.01 95.27 HOVANCAKOVA J, SCHORETSANITIS G, GRO.. | 1 0.01 95.28 HOVANCAKOVA J, SCHORETSANITIS G, GROZ.. | 1 0.01 95.29 HYODO H, NAGAO K, NAKAZATO N, SAITO E.. | 1 0.01 95.30 IINO T, MATSUO Y, YOSHIDA S, ET AL. P.. | 1 0.01 95.31 IIZUKA, J.. EFFICACY AND FEASIBILITY .. | 1 0.01 95.32 ISHIHARA S, KIOKA H, OHTANI T, ASANO .. | 1 0.01 95.33 ISHIIET AL. 2 CASES OF SEVERE HYPOGLY.. | 1 0.01 95.34 ISIDORO-GARCIA M, SANCHEZ-MARTIN A, G.. | 1 0.01 95.35 ISSA P, ROBERT P. FINGER, KATHRIN KRU.. | 1 0.01 95.36 ITO, H.. THE TREATMENT OF COEXISTING .. | 2 0.02 95.38 IWATA K, MASHIBA T, HITORA T, YAMAGAM.. | 1 0.01 95.39 JABBOUR E, KANTARJIAN HM, THOMAS DA, .. | 1 0.01 95.40 JACOBS, N.. REMARKABLE FINDING OF AN .. | 1 0.01 95.41 JARRETT, B.. CASE OF STEVEN-JOHNSON S.. | 1 0.01 95.42 JAVAID AI, LASTER J, SATOSKAR R. A RA.. | 1 0.01 95.43 JB C. HIGH DOSE INSULIN FOR BETA-BLOC.. | 1 0.01 95.44 JEONGSOO K, SEULKI L, HARYEONG R, CHU.. | 1 0.01 95.45 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 2 0.02 95.47 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 1 0.01 95.48 JONES N. SEPSIS DURING IMMUNOSUPPRESS.. | 2 0.02 95.50 JONES, N.. SEPSIS DURING IMMUNOSUPPRE.. | 1 0.01 95.51 JUBA, K.. MORPHINE AND HYDROMORPHONE-.. | 1 0.01 95.52 JUNG J, DELLA TORRE K, FELL M, TENG C.. | 1 0.01 95.53 JUSTER-SWITLYK, K.. MTHFR C677T POLYM.. | 1 0.01 95.54 KADIKOY H, PAOLINI M, ACHKAR K, SUKI .. | 1 0.01 95.55 KALAKOTA, N.. HEPATOXICITY IN A PATIE.. | 1 0.01 95.56 KALYAN S. CAN PERIPHERAL BLOOD T CELL.. | 1 0.01 95.57 KAMEOKA Y, TAKAHASHI N, ISHIZAWA K, K.. | 1 0.01 95.58 KAN R, HIKITA M, UEJIMA M, YABE M. GE.. | 1 0.01 95.59 KANEKO M ET AL.. A CASE OF ACUTE LYMP.. | 1 0.01 95.60 KANKICHI TAKAHASHI. THREE CASES WITH .. | 1 0.01 95.61 KANO K, KATAYAMA T, TAKEGUCHI S, ASAN.. | 1 0.01 95.62 KANO, K. BIOPSY-PROVEN CASE OF EPSTEI.. | 1 0.01 95.63 KANTROVA E, MICHALIK J, KURCA E. PROG.. | 1 0.01 95.64 KAPILA A, CHHABRA L, LOCKE AD, PATEL .. | 1 0.01 95.65 KAPP M, KOSMALA A, KIRCHER S, LUBER V.. | 1 0.01 95.66 KAPP, M.. EXCEPTIONAL RESPONSE TO NAN.. | 1 0.01 95.67 KARASAWA K, UCHIDA K, ASAMIYA Y, MORI.. | 11 0.11 95.78 KARASAWA K, UCHIDA K, ASAMIYA Y, MORI.. | 1 0.01 95.79 KARAVASILIS, V.. GEMCITABINE COMBINED.. | 2 0.02 95.81 KARIMATA K, MASUKO M, USHIKI T, KOZAK.. | 1 0.01 95.82 KARVUNIDIS T, HARAZIM M, RADEJ J, NOV.. | 1 0.01 95.83 KATO K, MICHISHITA Y, OYAMA K, HATANO.. | 1 0.01 95.84 KATO K, MICHISHITA Y, OYAMA K, HATANO.. | 1 0.01 95.85 KATO M, MATSUDA H, UCHIDA S, ET AL. I.. | 1 0.01 95.86 KATO, K.. PREGABALIN-AND AZITHROMYCIN.. | 1 0.01 95.87 KATOWITZ, W.. AN ASYSTOLIC EVENT AFTE.. | 1 0.01 95.88 KATSIFIS G. LONG-TERM EFFICACY AND SA.. | 1 0.01 95.89 KAWASAKI Y. LONG-TERM EFFECT AFTER TH.. | 1 0.01 95.90 KEIR M, DEHGHANI P. CORTICOSTEROIDS A.. | 1 0.01 95.91 KEIR, M.. CORTICOSTEROIDS AND SPONTAN.. | 1 0.01 95.92 KELLY B, LOCKE B, KELLY K. PSEUDOALLE.. | 1 0.01 95.93 KELLY BT, LOCKE BA, KELLY KJ. OCULAR .. | 1 0.01 95.94 KELLY BT, LOCKE BA, KELLY KJ. PSEUDOA.. | 1 0.01 95.95 KELLY BT, LOCKE BA, KELLY KJ. PSEUDOA.. | 1 0.01 95.96 KELLY D, GEOTTMAN D, SARODIA B.. CHEM.. | 1 0.01 95.97 KENES MT, HAMBLIN SE, TUMULURI SS, GU.. | 1 0.01 95.98 KHAN R, SATTI S. ADULT PULMONARY BLAS.. | 1 0.01 95.99 KHAN, S.. NICOTINE TOXICITY IN A NURS.. | 1 0.01 96.00 KHOBRANI MA, DUDLEY SW, HUCKLEBERRY Y.. | 1 0.01 96.01 KHWAJA GA, DUGGAL A, KULKARNI A, CHOU.. | 1 0.01 96.02 KIBA T, MEGURO T. A CASE OF ADVANCED .. | 1 0.01 96.03 KINDLE S. LENALIDOMIDE TREATMENT OF C.. | 1 0.01 96.04 KINOSHITA H, TANAKA N, JAMAL M, KUMIH.. | 1 0.01 96.05 KIRSACLIOGLU C, KULOGLU Z, USTUNDAG G.. | 1 0.01 96.06 KITAJIMA, T. SEQUENTIAL ADJUVANT CHEM.. | 1 0.01 96.07 KITANI Y, KUBOTA A, FURUKAWA M, SATO .. | 1 0.01 96.08 KLEINMANN JF, ARNAUD L, SAULEAU E, .. | 1 0.01 96.09 KOBAYASHI M. A VERIFICATION OF HISTOP.. | 1 0.01 96.10 KOBAYASHI N, JINGU A, HACHISU K, ONO .. | 1 0.01 96.11 KOBORI I. A CASE OF CHRON^S DISEASE C.. | 1 0.01 96.12 KOIDE T, SARAYA T, NAKAMOTO K, NAKAJI.. | 1 0.01 96.13 KOIKE N, WATANABE H, ARITA S, TAKEUCH.. | 1 0.01 96.14 KOIKE, N.. LONG-TERM SUCCESSFUL MANAG.. | 1 0.01 96.15 KOLTHOF HJ.. AUDITORY HALLUCINATIONS:.. | 1 0.01 96.16 KOMAKI W., FUKANOGI T., FUNAMOTO T., .. | 1 0.01 96.17 KORNHOLT J, ET,AL. FENTANYL/MORPHINE/.. | 1 0.01 96.18 KORNHOLT J. SECONDARY ADRENAL INSUFFI.. | 1 0.01 96.19 KOSCHNY R, JUNGHANSS T, MISCHNIK A, K.. | 1 0.01 96.20 KRISHNAMOORTHY T, KNIGHTON J, MERTON .. | 1 0.01 96.21 KRUGER T, JOCKERS-SCHERUBL M, GROHMAN.. | 1 0.01 96.22 KRUGER, T.. DEVELOPMENT OF EPILEPTIC .. | 1 0.01 96.23 KUDLICKI J, KANIA A, FRANIA-BARYLUK A.. | 1 0.01 96.24 KUDO K, KISHIMOTO K, HARADA T, TAKAYA.. | 1 0.01 96.25 KUMAR B, STROUSE J, SWEE M, LENERT P,.. | 4 0.04 96.29 KUNOS C, DENG W, DAWSON D, LEA J, ZAN.. | 1 0.01 96.30 KUNOS C, DENG W, DAWSON D, LEA JS, ZA.. | 1 0.01 96.31 KUNOS C, DENG W, DAWSON D, LEA JS, ZA.. | 1 0.01 96.32 KUNOS C, DENG W, DAWSON D, LEA JS, ZA.. | 1 0.01 96.33 KUNOS C, DENG W, DAWSON D, LEA JS, ZA.. | 3 0.03 96.36 KUNOS C, DENG W, DAWSON D, LEA SJ, ZA.. | 1 0.01 96.37 KURIHARA K, AMANO K, SAKATA K, TOYODA.. | 1 0.01 96.38 KUROI K, YAMASHITA T, ARUGA T, HORIGU.. | 1 0.01 96.39 KURSUN H, DIEHL C, GELDNER G. DEATH .. | 1 0.01 96.40 KUSTERMANN, A.. DEPRESSION AND ATTEMP.. | 2 0.02 96.42 KUTLU A, KARABACAK E, AYDIN E, OZTUR.. | 1 0.01 96.43 KUTUK M, OZGUN M, ULUDAQ S, DOLANBAY .. | 2 0.02 96.45 LAES JR, HENDRIKSEN S, COLE JB USE OF.. | 1 0.01 96.46 LAGMAN J, AJITA M. A CASE OF INTERFER.. | 1 0.01 96.47 LE VAILLANT, J.. ACETAMINOPHEN (PARAC.. | 1 0.01 96.48 LEE CYS, SUZUKI JB. MEDICATION-RELATE.. | 1 0.01 96.49 LEE CYS, SUZUKI JB. MEDICATION-RELATE.. | 1 0.01 96.50 LEFEBVRE DR, MANDEVILLE JT, YONEKAWA .. | 1 0.01 96.51 LELONG J, VENISSE N, HOUPERT T, BRUNE.. | 1 0.01 96.52 LEPELLETIER D, BEMER P, BESSON J, CAZ.. | 1 0.01 96.53 LEPELLEY M.. DIMINUTION OF CLINDAMYCI.. | 1 0.01 96.54 LEUNG JG, BARRETO JN, THOMPSON CA LYM.. | 1 0.01 96.55 LEVALAMPI T, KORPELA M, VUOLTEENAHO K.. | 1 0.01 96.56 LEVALAMPI T, KORPELA M, VUOLTEENAHO K.. | 2 0.02 96.58 LINDER F, GRAF W, EDHOLM D.. LETTER T.. | 1 0.01 96.59 LITERATURE REFERENCE: CUMPSTON KL, G.. | 1 0.01 96.60 LITERATURE REFERENCE: SANNA GD, TALAN.. | 1 0.01 96.61 LLADO, L.. CANDIDA ARTERITIS OCCURRIN.. | 1 0.01 96.62 LLOYD-LAVERY A, ASHER R, TURNER R, ES.. | 1 0.01 96.63 LLOYD-LAVERY A, ASHER R, TURNER R, ES.. | 1 0.01 96.64 LODGE JA, DASGUPTA D, PRASAD K, ATTIA.. | 1 0.01 96.65 LOGAN B, GOLDFOGEL G, HAMILTON R, KUH.. | 1 0.01 96.66 LOPEZ PARDO, P.. MYOCLONUS DUE TO FEN.. | 1 0.01 96.67 LUDLOW SP, CHEHAB SS.. DOCETAXEL/CYCL.. | 1 0.01 96.68 LUND J, GRUBER A, BLIMARK C, LAURI B,.. | 1 0.01 96.69 LWIN T, GALAL N, GERA S, MARTI J.. AD.. | 1 0.01 96.70 LWIN, T.. ADRENAL CUSHING SYNDROME WI.. | 1 0.01 96.71 M BURLANDO. BILATERAL WARTHIN TUMOR I.. | 1 0.01 96.72 MA H. METHOTREXATE AND ETANERCEPT-IND.. | 1 0.01 96.73 MADIAS J. VENLAFAXINE AND TAKOTSUBO S.. | 1 0.01 96.74 MADIAS, J.. VENLAFAXINE AND TAKOTSUBO.. | 1 0.01 96.75 MAGRENI A, OBERMAN B, BAKER A, ANDREW.. | 1 0.01 96.76 MAHAJAN A, LADDHAD D, BOHARA D, LADDH.. | 1 0.01 96.77 MAHMOOD MM, WRIGHT R. SPONTANEOUS COR.. | 1 0.01 96.78 MAKKUNI D, KENT R, WATTS R, CLUNIE G... | 1 0.01 96.79 MALIK S, WONG SC, BISHOP J, HASSAN K,.. | 1 0.01 96.80 MANCANO M. GARCINIA CAMBOGIA-INDUCED .. | 1 0.01 96.81 MANGASAROVA IAK, BARIAKH EA, VOROB^EV.. | 1 0.01 96.82 MANSOUR, Y.. PLEURISY INDUCED BY ATOR.. | 1 0.01 96.83 MARRAFFA JM, HOLLAND MG, SULLIVAN .. | 1 0.01 96.84 MARTIN B, JIMENEZ HERNANDEZ M, PRADO .. | 1 0.01 96.85 MARTINEZ-MORENO R, AGUILAR M, WENDL .. | 1 0.01 96.86 MARTINEZ-MORENO, R.. FATAL THROMBOSIS.. | 1 0.01 96.87 MASAROVA L. UPDATED RESULTS OF PHASE .. | 1 0.01 96.88 MASSELINK JB, SPORTEL ET, COLEN HBB.... | 1 0.01 96.89 MASSELINK, J.. INTOXICATION AFTER ING.. | 1 0.01 96.90 MASSEY T, SMITH R, SADIQ S, OVERTON C.. | 1 0.01 96.91 MATACENA M. WRITING IS DIFFICULT FOR .. | 1 0.01 96.92 MATSUI, A.. TREATMENT OF ACQUIRED REA.. | 1 0.01 96.93 MATTA A, ASSALIE NA, GUPTA RK, DEL PI.. | 1 0.01 96.94 MCALLISTER BP, WILLIAMS ED, YOO LJ, T.. | 1 0.01 96.95 MEDANI S, WALL C.. COLCHICINE TOXICIT.. | 1 0.01 96.96 MEDRANO-CASIQUE N, TONG H, BOROBIA A,.. | 1 0.01 96.97 MEIJDEN EVD, HORVATH B, NIJLAND M, DE.. | 1 0.01 96.98 MENG, H.. THE PRESCRIPTION OF MEDICAL.. | 1 0.01 96.99 METAYER B, MENU P, KHATCHATOURIAN L, .. | 1 0.01 97.00 MEURER L, DAVITKOV P, POST A, COHEN S.. | 1 0.01 97.01 MICHELS G, KOCHANEK M, PFISTER R. LIF.. | 2 0.02 97.03 MIHALCEA D, FLORESCU M, VLADAREANU AM.. | 1 0.01 97.04 MIKAMI Y., KAWAMOTO T., SHINADA Y., E.. | 1 0.01 97.05 MILONA M. PNEUMONIA AND BRAIN ABSCESS.. | 1 0.01 97.06 MITSUHASHI T, TAKAMIYA O. ACQUIRED FA.. | 1 0.01 97.07 MIYOSHI M, IRIE S, KURIHARA T, YAMADA.. | 1 0.01 97.08 MIZUGAMI Y. P114-6 TEPRENONE PROPHYLA.. | 1 0.01 97.09 MIZUNO S, HANAMURA I, OTA A, KARNAN S.. | 1 0.01 97.10 MOCHIZUKI, T.. NEGATIVE PRESSURE WOUN.. | 1 0.01 97.11 MOHAMED IQBAL I; MORRIS R; HERSCH M. .. | 1 0.01 97.12 MOILANED E, LEVALAMPI T, KORPELA M, V.. | 1 0.01 97.13 MOLTENIS M.. CARDIOGENIC SHOCK DUE TO.. | 1 0.01 97.14 MORELLI C, FORMICA V, GUARINO MD, CER.. | 1 0.01 97.15 MORELLI C, FORMICA V, GUARINO MD, CER.. | 1 0.01 97.16 MORELLI C, FORMICA V, PELLICORI S, ME.. | 1 0.01 97.17 MORELLI C. CHEMOTHERAPY IN PATIENTS W.. | 1 0.01 97.18 MORIWAKA O. USE OF AROMATASE INHIBITO.. | 1 0.01 97.19 MORROW JI, RUSSELL A, GUTHERIE E, PAR.. | 1 0.01 97.20 MOSHOLDER AD, TAYLOR L, MANNHEIM G, O.. | 1 0.01 97.21 MOTOHIRO T ET AL.. A CASE OF CML PATI.. | 1 0.01 97.22 MULHOLLAND C P, POLLOCK T J.. THE PET.. | 1 0.01 97.23 MULLER, S.. INTRALIPID EMULSION RESCU.. | 1 0.01 97.24 MUNABI, N.. GROWTH HORMONE INDUCES RE.. | 1 0.01 97.25 MURAKAMI, H.. A CASE OF COMBINED MODA.. | 1 0.01 97.26 MURAKAMI, J.. A CASE OF BILATERAL PNE.. | 1 0.01 97.27 MURSLEEN, A.. ADRIAMYCIN CARDIOMYOPAT.. | 1 0.01 97.28 M^KADA H, PERAZZO H, MUNTEANU M, NGO .. | 1 0.01 97.29 NADEGE W, BIHAN K, CEZ A, SIMON L, BI.. | 1 0.01 97.30 NAGASAKI A, MIYAGI T, NAKACHI S, TAKA.. | 1 0.01 97.31 NAKAJIMA T, INOUE T, KAIDA K, OKIKAWA.. | 1 0.01 97.32 NAKAJIMA, K.. PREGNANCY OUTCOMES AFTE.. | 1 0.01 97.33 NALLY, E.. ACUTE DIFFUSE TENDINOPATHY.. | 1 0.01 97.34 NAPIER C, GAN EH, PEARCE SH. LOPERAMI.. | 1 0.01 97.35 NARUSE N. JAPANESE JOURNAL OF ALCOHOL.. | 1 0.01 97.36 NATH A, PAUL B, GOLOCOVSKY M, SHOPE T.. | 1 0.01 97.37 NATH, A.. AN UNUSUAL CASE OF UPPER AB.. | 1 0.01 97.38 NEAL JM, SALINAS FV, CHOI DS. LOCAL A.. | 1 0.01 97.39 NEAL, J.. LOCAL ANESTHETIC-INDUCED MY.. | 1 0.01 97.40 NGUYEN P, SPINELLI C. PRESCRIBING CAS.. | 1 0.01 97.41 NGUYEN PVQ, SPINELLI C. PRESCRIBING C.. | 1 0.01 97.42 NGUYEN PVQ, SPINELLI C. PRESCRIBING C.. | 1 0.01 97.43 NGUYEN, P.. PRESCRIBING CASCADE IN AN.. | 1 0.01 97.44 NIKLAS, K.. POLYMYOSITIS INDUCED BY A.. | 1 0.01 97.45 NINAN J. IMIPENEM-CILASTATIN-INDUCED .. | 1 0.01 97.46 NISHIOKA S, MINE N, SHINDO K, KIOKA M.. | 1 0.01 97.47 NITTA D, IMAMURA T, KINUGAWA K, HATAN.. | 1 0.01 97.48 NITYA, S.. DOXYCYCLINE INDUCED GENERA.. | 1 0.01 97.49 NIU T, CHANG L, YANG J, LIU Y, DONG L.. | 1 0.01 97.50 NODA T, YAMAOKA A, EHAMA Y, AISAKA .. | 1 0.01 97.51 NORMAN H, ELFINEH M, BEIJER E, CASSWA.. | 1 0.01 97.52 NORMAN H, ELFINEH M, BEIJER E, ET AL... | 1 0.01 97.53 NOVITSKAYA, E.. SPONTANEOUS HAEMORRHA.. | 1 0.01 97.54 NYBERG L, RATHBUN R, NIHO H, ET AL. R.. | 1 0.01 97.55 OERTELT-PRIGIONE S, CROSIGNANI A, GAL.. | 1 0.01 97.56 OHNO T, KISHIMOTO W, CHIHARA D, SAKAM.. | 1 0.01 97.57 OHTA H, SATO N, KAWAMURA Y, HASEBE N... | 1 0.01 97.58 OIZUMI T, ENDO Y. A STRATEGY AGAINST .. | 1 0.01 97.59 OKUMURA Y. THE 9TH KYUSHU REGIONAL ME.. | 1 0.01 97.60 OLIVER N, LUONG T, TCHAKAROV A, ABDEL.. | 1 0.01 97.61 ONAI. A CASE OF BASEDOW^S DISEASE WHI.. | 1 0.01 97.62 ORIOLO G, BRUGUES A, GOIKOLEA JM, PIN.. | 1 0.01 97.63 ORIOLO G. LAMOTRIGINE INDUCED DRESS S.. | 1 0.01 97.64 ORIOLO G., BRUGU?S A., GOIKOLEA J.M.,.. | 1 0.01 97.65 OWEN L, THI AA, BOURI S, WOLFSON P, A.. | 1 0.01 97.66 OZTURK Z, OLMEZ E, GURPINAR T, VURAL .. | 1 0.01 97.67 OZTURK Z, OLMEZ E, GURPINAR T, VURAL .. | 1 0.01 97.68 P M. | 1 0.01 97.69 PACHECO, J.. HOW LOW IS TOO LOW: STAT.. | 1 0.01 97.70 PACI M, CHIAPPINI E, TRAPANI S, RESTI.. | 1 0.01 97.71 PAINHAS T, AMORIM M, SOARES R, DUARTE.. | 1 0.01 97.72 PAINHAS, T.. IDIOPATHIC INTRACRANIAL .. | 1 0.01 97.73 PANIGRAHI I, KUMAR C, ARADHYA AS, MEE.. | 1 0.01 97.74 PAPAKOSTAS TD, LE H, CHODOSH J, JACOB.. | 1 0.01 97.75 PAPAROUPA M, PIETRZAK S, GILLISSEN A... | 1 0.01 97.76 PARISI M, ZAYED H, SLAVOTINEK A M, RU.. | 1 0.01 97.77 PAULKE A, WUNDER C, TOENNES SW.. SLEE.. | 1 0.01 97.78 PEREZ PARENTEA D, SUAREZ SANTAMARIA M.. | 1 0.01 97.79 PETERS SS, BETTINGER J, PHILIP J, KAR.. | 1 0.01 97.80 PETITPAIN N, GAMBIER N, WAHL D, CHAR.. | 1 0.01 97.81 PHAM, A.,HARIRI, S.,YUSIN, J.. TIMING.. | 1 0.01 97.82 PIERCE L, HA K, KATZ K, JAMES PR, CHO.. | 1 0.01 97.83 PINTO J, SHEIKH I, PABONA J, CULPEPPE.. | 1 0.01 97.84 PINTO J, SHEIKH I, PABONA JM, CULPEPP.. | 1 0.01 97.85 PODOBINSKI TK, MIMBELLA PC, CACHOLA K.. | 1 0.01 97.86 POGLIANI, D.. NONCONVULSIVE STATUS EP.. | 1 0.01 97.87 POLITIKOS I, MCMASTERS M, BRYKE C, AV.. | 1 0.01 97.88 POPAT S, FELIP E, COBO M, FULOP A, DA.. | 1 0.01 97.89 POZZILLI C, PHILLIPS J, FOX R, PRADA .. | 1 0.01 97.90 PRATT, J.. SUSPECTED PIPERACILLIN-TAZ.. | 1 0.01 97.91 PRIOTY I, CATHERINE D, LAUREN S, ADAM.. | 1 0.01 97.92 PULVIRENTI, F.. ENDOCARDITIS IN PATIE.. | 1 0.01 97.93 RACHOW T, DORNAUS S, SAYER H, HERMANN.. | 1 0.01 97.94 RACHOW T, DORNAUS S, SAYER HG, HERMAN.. | 1 0.01 97.95 RAJAN D, GREER JB, REGUEIRO MD, BAIDO.. | 1 0.01 97.96 REINHOLZ M, EDER I, PRZYBILLA B, SCHA.. | 1 0.01 97.97 RENET S, CLOSON A, BROCHET MS, BUSSIE.. | 1 0.01 97.98 RESEARCH AND PRACTICE IN THROMBOSIS A.. | 1 0.01 97.99 RICHARDSON, E.. DELAYED ONSET ACUTE L.. | 1 0.01 98.00 RIMSZA ME, NEWBERRY S. UNEXPECTED INF.. | 1 0.01 98.01 RIZEK, P. BOWEL ISCHEMIA IN REFRACTOR.. | 1 0.01 98.02 RIZEK, P.. BOWEL ISCHEMIA IN REFRACTO.. | 1 0.01 98.03 ROBAK, T.. FRONTLINE BORTEZOMIB, RITU.. | 1 0.01 98.04 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 1 0.01 98.05 ROCCHI F, BAIARDI P, BARBIERI I, DEL .. | 1 0.01 98.06 ROCCHI, F.. CAUTION ON THE USE OF NSA.. | 1 0.01 98.07 RODRIGUEZ B. RESPONSE TO DIFFERENT TH.. | 1 0.01 98.08 RODRIGUEZ-VILLAR C, CONGET I, FERRER-.. | 1 0.01 98.09 ROTA E, VALLISA D, MORELLI N, SCAGNEL.. | 1 0.01 98.10 ROTA, E.. IATROGENIC COAGULOPATHY AND.. | 1 0.01 98.11 RUGGIERI S, DE GIGLIO L. LISTERIA MON.. | 1 0.01 98.12 RUIZ RAMOS J, ROMA E, PALOMAR L, POVE.. | 1 0.01 98.13 RUSH S, FOREMAN N AND LIU A. BRAINSTE.. | 1 0.01 98.14 RUSSELL JAMES A.. DURABLE EVENT-FREE .. | 1 0.01 98.15 RUWALD MH, RUWALD AH, TONDER N. MET.. | 1 0.01 98.16 SACCO K,MOUSA O,WANG M. CHRONIC ABDOM.. | 1 0.01 98.17 SACCO KA, MOUSA OY, WANG MH. CHRONIC .. | 1 0.01 98.18 SAGEZ F, ARNAUD L, GOTTENBERG J, JAVI.. | 2 0.02 98.20 SAKAMOTO K, MURASE T, UENO C, NISHIGA.. | 1 0.01 98.21 SALARBAJALAR. ATYPICAL FEMORAL FRACTU.. | 1 0.01 98.22 SALIK J, TANG R, NORD K, SCHNEIDERMAN.. | 1 0.01 98.23 SANCHEZ L, GUIJO AR, RUIZ SSC, PORRAS.. | 1 0.01 98.24 SARTORI D, CARVAJAL A.. QUETIAPINE AN.. | 1 0.01 98.25 SATO E, NITTA H, HAMANO Y, OSHIMI K. .. | 1 0.01 98.26 SATO M, TOMIYA Y, TAKAYA N, KAMATA R,.. | 1 0.01 98.27 SATO R, AKIMOTO T, IMAI T, NAKAGAWA S.. | 1 0.01 98.28 SATO, K.. A CASE OF CARDIAC ARREST CA.. | 1 0.01 98.29 SATORU KODAMA. EFFICACY AND SAFETY O.. | 1 0.01 98.30 SCARPAZZA S, DE ROSSI N, TABIADON G, .. | 1 0.01 98.31 SCHALLER J, CARLSON J. ERYTHEMA NODOS.. | 1 0.01 98.32 SCHALLER J, CARLSON J.A. ERYTHEMA NOD.. | 1 0.01 98.33 SCHERL TA, LANGGUTH B, KREUZER PM.. H.. | 1 0.01 98.34 SCHERNECK S, SCH?PA FL, ENTEZAMI M, K.. | 1 0.01 98.35 SCHIESSI B, SCHNELDER K, ZIMMERMANN A.. | 1 0.01 98.36 SCHIMKE KE, GREMINGER P, BRANDLE M. S.. | 1 0.01 98.37 SCHMIDT, S.. SEVERE GEMCITABINE ASSOC.. | 1 0.01 98.38 SCHMUTZ, J.. LUPUS ERYTHEMATOSUS AND .. | 1 0.01 98.39 SCHNEIDER C, LESTIN M, DIWOK C, SCHNE.. | 1 0.01 98.40 SCHRAGE B, GRAHN H, WAGNER F, BERNHAR.. | 1 0.01 98.41 SEBASTIAN A, MISTERSKA-SKORA M, PODOL.. | 1 0.01 98.42 SEHRA S, JAGGI S, SEHRA D, AGGARWAL R.. | 1 0.01 98.43 SEIKO MITUSI. POSSIBLE MACROPHAGE ACT.. | 1 0.01 98.44 SEIRAFI M, VROEY BD, AMIOT A, SEKSIK .. | 1 0.01 98.45 SELBST SM, OSTERHOUDT K. PEDIATRIC EM.. | 1 0.01 98.46 SHAH D, FISHER C, WILSON S, GUTKIN E... | 1 0.01 98.47 SHAH D, FISHER C, WILSON S, GUTKIN E... | 1 0.01 98.48 SHAH, D.. ANTIBIOTIC-INDUCED STAPHYLO.. | 1 0.01 98.49 SHEPHERD, S.. FATAL CARDIOVASCULAR IN.. | 1 0.01 98.50 SHERRILL M, THELIN C, MARKWELL P, BAL.. | 1 0.01 98.51 SHIBATA S.. A CASE OF ATYPICAL FEMORA.. | 1 0.01 98.52 SHIGA K, KATAGIRI K, SAITOH D, OGAWA .. | 1 0.01 98.53 SHIMA, T.. A PATIENT WITH REFRACTORY .. | 1 0.01 98.54 SHIMATANI A. SECONDARY OSTEOSARCOMA I.. | 2 0.02 98.56 SHIMOKAZE T, MITSUI T, KAWAKAMI T, AR.. | 1 0.01 98.57 SHINODA, Y.. POTENTIAL DRUG INTERACTI.. | 2 0.02 98.59 SHINODA, Y.. POTENTIAL DRUG INTERACTI.. | 1 0.01 98.60 SHOKO Y, KOJI K, SHOHEI D, AKANE S, H.. | 1 0.01 98.61 SHOKO Y, KOJI K, SHOHEI D,AKANE S,HIR.. | 1 0.01 98.62 SHREYA A SHAH, ALISON GULBIS, KACI WI.. | 1 0.01 98.63 SHUMAKER AC, BULLARD HM, CHURPEK J, K.. | 1 0.01 98.64 SIDDIQUE I, MAHMOOD H, MOHAMMED AR, R.. | 1 0.01 98.65 SIGIREDDI R, MOFFETT J, KEUHT M, ACKA.. | 1 0.01 98.66 SINGH P, SINHA A, KAMATH A, MALHOTRA .. | 1 0.01 98.67 SINGH V, DEVATA S, CHENG YC;. CARBOPL.. | 1 0.01 98.68 SINGH, P.. VERY SEVERE APLASTIC ANAEM.. | 1 0.01 98.69 SKEID M, PEDERSEN-BJERGAARD U, KRISTE.. | 1 0.01 98.70 SKOVBOLLING SL, LINDELOF M. MYOPATHY .. | 1 0.01 98.71 SKOVBOLLING SL, LINDELOF M... MYOPATH.. | 1 0.01 98.72 SNYDER, M.. SERTRALINE-INDUCED RHABDO.. | 1 0.01 98.73 SONODA A, WADA K, MIZUKAMI K, FUKUDA .. | 1 0.01 98.74 SOUSA MJCS, CADINHA S, MOTA M, TEIXEI.. | 1 0.01 98.75 SPIEGEL, M.. A RARE CASE OF METHOTREX.. | 1 0.01 98.76 SPRAKES M, HAMLIN J, WARREN L, GREER .. | 1 0.01 98.77 SPRAKES M, HAMLIN J, WARREN L, GREER .. | 1 0.01 98.78 STRAUS D, PITCHER B, KOSTAKOGLU L, GR.. | 1 0.01 98.79 SUZUKI S. BENAZEPRIL/ VALSARTAN: HYPE.. | 1 0.01 98.80 SUZUKI T, MIYAKOSHI S, NANBA A, KAWAM.. | 1 0.01 98.81 SUZUKI, Y.. ENDOSCOPIC TREATMENT FOR .. | 1 0.01 98.82 SWINNEN I. OCCUPATIONAL AIRBORNE CONT.. | 1 0.01 98.83 SYKES, C.. SUDDEN UNEXPLAINED DEATH I.. | 1 0.01 98.84 SZENCZI O, KARLOCAI K, RIGO J, BUCSEK.. | 1 0.01 98.85 TABNER A., JOHNSON G.. CODEINE: AN UN.. | 1 0.01 98.86 TAFESH Z, O^NEIL S, CRAWFORD J. FECAL.. | 1 0.01 98.87 TAFESH Z, O^NEIL S, CRAWFORD J. FECAL.. | 1 0.01 98.88 TAFESH Z, O^NEIL S, CRAWFORD JR C. FE.. | 1 0.01 98.89 TAFESH, Z.. FECAL MICROBIOTA TRANSFER.. | 1 0.01 98.90 TAKACS, R.. CATATONIA IN DISULFIRAM I.. | 1 0.01 98.91 TAKAHASHI J, KUMAKURA M, OKAWA M, TOM.. | 1 0.01 98.92 TAKAHO N. THREE CASES OF CROHN^S DISE.. | 1 0.01 98.93 TAKAKI M, TANAKA T, KOMOHARA Y, TSUCH.. | 1 0.01 98.94 TAKAKI M, TANAKA T, KOMOHARA Y, TSUCH.. | 1 0.01 98.95 TAKASHI HERAI, ET AL.. EVALUATION OF .. | 1 0.01 98.96 TAKESHI SHIBATA ET AL.,. THE 50TH ANN.. | 1 0.01 98.97 TAN CJ, SKLAR GE. CHARACTERISATION AN.. | 1 0.01 98.98 TAN CJ, SKLAR GE. CHARACTERISATION AN.. | 1 0.01 98.99 TANAKA T, KUDO T, TANI M, ET AL. A CA.. | 1 0.01 99.00 TANAKA, K. THE EFFECTS OF MITIGLINIDE.. | 1 0.01 99.01 TANAKA, M. A CASE THAT PRESENTED WITH.. | 1 0.01 99.02 TERADA A. A CHILD CASE OF XERODERMA .. | 1 0.01 99.03 TESCHKE, R.. IBUPROFEN/PARACETAMOL/TR.. | 1 0.01 99.04 THURTELL, C.. ONE SIZE DOES NOT FIT A.. | 1 0.01 99.05 TILLY H, MORSCHHAUSER F, CASANOVAS O,.. | 1 0.01 99.06 TILLY H, MORSCHHAUSER F, CASASNOVAS O.. | 1 0.01 99.07 TIMMER SJ, NONNER TSE.. CLOZAPINE AND.. | 1 0.01 99.08 TOKUDA, T.. A CASE OF SEVERE VISCERAL.. | 1 0.01 99.09 TOMIDA, E.. CAUSATIVE DRUG DETECTION .. | 1 0.01 99.10 TOMITA A, SATANI M, SUZUKI K, KAJI A,.. | 1 0.01 99.11 TOMITA. A CASE OF POOR WEIGHT GAIN IN.. | 1 0.01 99.12 TOMOKO KAWAI. CADEX? OINTMENT AND ORA.. | 1 0.01 99.13 TOUZEAU C, MOREAU P. HOW I TREAT EXTR.. | 1 0.01 99.14 TOYOKAWA, A.. A CASE OF HYPERAMMONEMI.. | 1 0.01 99.15 TRAINA TA, KAUFMAN PA, CADOO KA, HUD.. | 1 0.01 99.16 TSUHA S, TANIGUCHI T, SHIIKI S, NARIT.. | 2 0.02 99.18 TSUZUKI.M, INAGUMA.Y, HANDA.K, HASEGA.. | 1 0.01 99.19 UBE K, ET AL. A CASE OF LUNG ADENOCAR.. | 1 0.01 99.20 UEDA Y. A CASE OF SUCCESSFUL BEVACIZU.. | 1 0.01 99.21 UEDA, T.. BEVACIZUMAB HELPED RESOLVE .. | 1 0.01 99.22 UNKNOWN U, SAIJO T, TANAKA A, IKEDA N.. | 1 0.01 99.23 UNKNOWN U, SAIJO T, TANAKA A, IKEDA N.. | 1 0.01 99.24 UNKNOWN U, SATO Y, TAKAHASHI A, TERAK.. | 1 0.01 99.25 USE OF HYPERBARIC OXYGEN THERAPY IN Q.. | 1 0.01 99.26 UTSUNOMIYA A, ET AL. A CASE OF MALIGN.. | 1 0.01 99.27 VAN DE LAARSCHOT D. PAMIDRONIC ACID/R.. | 1 0.01 99.28 VAN DE MHEEN L, SMITS SM, TERPSTRA WE.. | 1 0.01 99.29 VAN EYNDE M, LECLUYSE K, CHIOCCIOLI C.. | 1 0.01 99.30 VAN KUILENBURG AB, MEIJER J, MAURER D.. | 1 0.01 99.31 VAN LANDINGHAM, S.. A CASE REPORT: CO.. | 1 0.01 99.32 VANCLEAVE, H.. PROBABLE METRONIDAZOLE.. | 1 0.01 99.33 VANYA M. PREGNANCY AND PERINATAL OUTC.. | 1 0.01 99.34 VASANT D, LIMDI J, BORG-BARTOLO S, BO.. | 1 0.01 99.35 VASSALLO M. ET AL. SELECTION OF THE R.. | 1 0.01 99.36 VECHT C, ROYER-PERRON L, HOUILLIER C,.. | 1 0.01 99.37 VERSON J, KENT P. SEVERE RADIATION RE.. | 1 0.01 99.38 VIET-QUOC NGUYEN P., SPINELLI C. PRES.. | 1 0.01 99.39 VIET-QUOC NGUYEN P., SPINELLI C.. PRE.. | 1 0.01 99.40 VILLARI V ET AL.. PSYCHIATRIC SYMPTOM.. | 1 0.01 99.41 VINCENZO D, URSO DL, CURIA A, SCATTAR.. | 1 0.01 99.42 VINET E, MOURA CS, CURTIS JR, PINEAU .. | 1 0.01 99.43 VINI D, SERVOS P, DROSOU M. NORMAL PR.. | 1 0.01 99.44 VOHRA A. QUETIAPINE INDUCED RESTLESS .. | 1 0.01 99.45 VOLDBY R, BAJALAR S. ATYPICAL FEMORAL.. | 1 0.01 99.46 VOLDBY RGH ET AL.. LAMOTRIGINE. ATYPI.. | 1 0.01 99.47 VOLDBY RGH, BAJALAN S.. ATYPICAL FEMO.. | 1 0.01 99.48 VOLKL SJ. EXCELLENT BIOCHEMICAL RESPO.. | 1 0.01 99.49 VON DOELLINGER O, RIBEIRO JP, RIBEIR.. | 1 0.01 99.50 VON KUMMER R, ALLEN K, HOLLE R, BOZZA.. | 1 0.01 99.51 VOORE P, ODIGWE C, MIRRAKHIMOV E, RIF.. | 1 0.01 99.52 WACHTEL, L.. NEUROLEPTIC MALIGNANT SY.. | 1 0.01 99.53 WARD L, GEORGE J. CORTICOSTEROID-INDU.. | 1 0.01 99.54 WARD L, JOJI G. CORTICOSTEROID-INDUCE.. | 1 0.01 99.55 WARNKE C. THE CSF JCV ANTIBODY INDEX .. | 1 0.01 99.56 WATANABE S ET AL.. A CASE OF DASATINI.. | 1 0.01 99.57 WEBER-SCHOENDORFER C, CHAMBERS C, WAC.. | 5 0.05 99.62 WEISKOPF K, CREIGHTON D, LEW T, CASWE.. | 1 0.01 99.63 WILKINSON D, WINDFELD K, COLDING-JORG.. | 1 0.01 99.64 WILLIAMS GS, GOODWIN R, HUGHES D. AML.. | 1 0.01 99.65 WILLIAMS, G.S. AMLODIPINE AS A CAUSE .. | 1 0.01 99.66 WILLIAMS, J.. SAFETY AND CLINICAL RES.. | 1 0.01 99.67 WITKOWSKI M,MOCHMANN H,RAUCH U,KNIE W.. | 1 0.01 99.68 WOODCOCK H, NELSON M. BURKITT^S NON-H.. | 1 0.01 99.69 WORTMANN G. TESTING FOR BORRELIA MIYA.. | 1 0.01 99.70 WROBEL A, RECHBERGER E, MAGNOWSKA M, .. | 1 0.01 99.71 WU M, GABRIELS J, KHAN M, SHABAN N, D.. | 2 0.02 99.73 WU M, GABRIELS J, KHAN M, SHABAN N, D.. | 1 0.01 99.74 YAGOU K.. CURRENT STATUS AND MANAGEME.. | 1 0.01 99.75 YAMAMOTO H, TAKAYAS T, NOSAKA M, AKIH.. | 1 0.01 99.76 YAMAMOTO, H.. FATAL ACUTE INTOXICATIO.. | 1 0.01 99.77 YAMASHINA T. PROSPECTIVE SMALL BOWEL .. | 1 0.01 99.78 YAMASHINA, T.. PROSPECTIVE SMALL BOWE.. | 2 0.02 99.80 YAMASHINAA T. PROSPECTIVE SMALL BOWEL.. | 1 0.01 99.81 YANAGISHITA, T.. A CASE OF IDIOPATHIC.. | 1 0.01 99.82 YANG A, BROWN J, MAK E. PERSISTENT DI.. | 1 0.01 99.83 YAPO-KOUADIO CG ET AL. REFRACTORY SEP.. | 1 0.01 99.84 YAPO-KOUADIO, C.. REFRACTORY SEPTIC S.. | 1 0.01 99.85 YEONG T, LIM K, GOUBET S, PARNELL N, .. | 1 0.01 99.86 YEONG TT, LIM KHJ, GOUBET S, PARNELL .. | 1 0.01 99.87 YEONG, T.. NATURAL HISTORY AND OUTCOM.. | 2 0.02 99.89 YONAL, I.. THE CO-PRESENCE OF DELETIO.. | 1 0.01 99.90 YOSHIKAWA, T. SAFETY PROFILE OF THE V.. | 1 0.01 99.91 YUKAWA T, YASUDA T T, KOJIMA A, SAISH.. | 1 0.01 99.92 ZAGELBAUM NK, MONDAL P, FRISHMAN WH, .. | 1 0.01 99.93 ZALAUDEK I, PICHLER N, WOLF I, DI MEO.. | 1 0.01 99.94 ZANTEK ND, ARNDT PA, LEGER RM, ZYDOWI.. | 1 0.01 99.95 ZARATE, M.. CHARACTERIZING THE USE OF.. | 1 0.01 99.96 ZAWAR I, CARO M, FELDMAN L, JIMENEZ X.. | 1 0.01 99.97 ZHENG L. METFORMIN AS A RARE CAUSE OF.. | 1 0.01 99.98 ZHENG L. METFORMIN AS A RARE CAUSE OF.. | 1 0.01 99.99 ZUIN M, GIORGINI A, SELMI C, BATTEZZA.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 7 Mar 2019